Salvatore Iovino currently serves as Senior Director of Bioanalytical and Biomarker Sciences at Editas Medicine since July 2024. Previously, Iovino held the position of Senior Director and Head of Translational Sciences at Carbon Biosciences, overseeing a team of seven scientists. At Sana Biotechnology, Inc., from March 2019 to February 2023, Iovino was Director of Non-Clinical Pharmacology, Biomarker, and Bioanalytical Development, where responsibilities included establishing and managing teams for pivotal pharmacology studies and developing translational biomarker strategies. Earlier roles include Group Leader and Associate Director of Cellular and Molecular Assay Development at Sana, Principal Scientist at Intellia Therapeutics, and Senior Scientist at Merck, focusing on cardiometabolic disease and drug screening innovations. Iovino obtained a Ph.D. in Molecular Oncology and Endocrinology and a Master's degree in Medical Biotechnologies from the University of Napoli 'Federico II'.
This person is not in any teams
This person is not in any offices